Literature DB >> 32600894

The potential use for patient reported outcome measures in people with pancreatic cancer, with a specific focus on older patients.

Peter De Rosa1, Anna Jewell2.   

Abstract

Pancreatic cancer is one of the most lethal malignancies and is characterised by high-unmet physical and psychological supportive care needs. Patient Reported Outcome Measures (PROMs) represent a patient centred approach to address the high unmet supportive care need and improve the quality of care. PROMs have the potential to inform patients about the quality of life and symptom trajectory for different treatment approaches so that they can fully participate in shared decisions about treatment. Embedding the collection of PROMs into routine practice alongside clinical alerts and directed symptom interventions is acceptable and feasible for people with pancreatic cancer and has the potential to reduce symptom burden. There is also limited information on survival, quality of life and the holistic impact of treatment for older pancreatic cancer patients, therefore, PROMs provide an opportunity to understand the impact of treatment on older patients and better inform shared treatment decision-making.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Elderly; Pancreatic cancer; Patient reported outcome measure; Patient reported outcomes; Shared decision-making

Year:  2020        PMID: 32600894     DOI: 10.1016/j.ejso.2020.05.010

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Baseline health-related quality of life predicts falls: a secondary analysis of a randomized controlled trial.

Authors:  Jennifer C Davis; Chun Liang Hsu; Cheyenne Ghag; Samantha Y Starkey; Patrizio Jacova; Larry Dian; Naaz Parmar; Kenneth Madden; Teresa Liu-Ambrose
Journal:  Qual Life Res       Date:  2022-07-07       Impact factor: 3.440

2.  NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma.

Authors:  Haitao Gu; Wensheng Deng; Yi Zhang; Yu Chang; Vishal G Shelat; Kunihiro Tsuchida; Leonardo S Lino-Silva; Zhaowen Wang
Journal:  Transl Lung Cancer Res       Date:  2022-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.